• Department of Thoracic Surgery, Tongji Medical College Affiliated Union Hospital, Huazhong University of Science and Technology, Wuhan 430000, P. R. China;
BAO Lihong, Email: xhzlzxz4@163.com
Export PDF Favorites Scan Get Citation

Neuromuscular disease (NMD) encompasses a group of disorders that affect motor neurons, peripheral nerves, neuromuscular junctions, and skeletal muscles, potentially leading to respiratory muscle impairment and decline in respiratory function, significantly impacting patients' quality of life. In March 2023, clinical practice guideline titled Respiratory Management of Patients with Neuromuscular Weakness was released by the American College of Chest Physicians. This article summarizes, categorizes, and interprets the contents and key points of the guideline, aiming to provide more targeted guidance for clinical healthcare professionals and ultimately enhance the effectiveness of respiratory management for patients with NMD.

Citation: GUO Yiqun, LUO Yang, SHEN Man, FENG Lijuan, SONG Yurong, BAO Lihong. Interpretation of the 2023 American College of Chest Physicians' respiratory management guidelines for patients with neuromuscular diseases. Chinese Journal of Evidence-Based Medicine, 2025, 25(1): 95-101. doi: 10.7507/1672-2531.202402120 Copy

Copyright © the editorial department of Chinese Journal of Evidence-Based Medicine of West China Medical Publisher. All rights reserved

  • Previous Article

    A methodological exploration of systematic reviews on disease burden